RxDoctor Payments Data

Evan Marlin, MD

Neurological Surgery · Fountain Hill, PANPI 1316251838

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,973 of the $2,638 with a category attached, or 74.8%. It is spread thinly across 12 manufacturers, the largest accounting for just 20.1%. That places this record below the midpoint for neurological surgery clinicians in PA, where the typical reported total is $3,234.

$2,638in general payments, 2019–2025

Across 32 payments — averaging $82.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$530
  • Philips North America LLC$486
  • Route 92 Medical, Inc.$403
  • Microvention, Inc.$278
  • Stryker$229
  • Imperative Care, Inc$204
  • plus $508 from 6 others
$16,303in research payments, 2019–2025

Across 13 payments — averaging $1254.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$10K
  • Medical Device Business Services, Inc.$7K

What the payments were for

  • Travel & lodging$66525%
  • Food & beverage$1,97375%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,638 in reported general payments places this provider in the 45th percentile of 390 neurological surgery providers in Pennsylvania.

See all neurological surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$109,570
Medicare patients
146
Services billed
431

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate19$204

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Fountain Hill

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →